Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Apellis Pharmaceuticals Inc
(NQ:
APLS
)
41.31
-0.69 (-1.64%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Apellis Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Apellis Pharmaceuticals Inc. (NASDAQ: APLS) Near the Top of Equities by Percentage Gain on 8/23
August 23, 2023
Via
Investor Brand Network
Crude Oil Edges Lower; VCI Global Shares Spike Higher
August 23, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Wednesday. The Dow traded up 0.40% to 34,425.29 while the NASDAQ rose 1.40% to 13,694.79. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Airbnb Versus New York Regulations, Netflix Adds New US Users After Password Crackdown, Facebook Marketplace Under Regulatory Fire For Alleged Sale Of Recalled Items: Top Stories
August 23, 2023
Wall Street Journal Airbnb Versus New York: What's Going On?
Via
Benzinga
Apellis Soars 28% After Identifying Potential Culprit Behind Eye Drug Safety Woes
August 23, 2023
Apellis has been investigating cases of eye inflammation following treatment with Syfovre.
Via
Investor's Business Daily
Why Is Apellis Pharmaceuticals Stock Shooting Higher Today?
August 23, 2023
Apellis Pharmaceuticals Inc (NASDAQ: APLS) released a comprehensive update regarding its Syfovre (pegcetacoplan injection) treatment for geographic atrophy (GA) secondary to age-
Via
Benzinga
DKS Stock Alert: Dick’s Sporting Goods Continues to Drop After Worst Day on Record
August 23, 2023
Dick's Sporting Goods (DKS) stock continues to see negative movement on Wednesday after experiencing a horrible fall on Tuesday.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 23, 2023
Via
Benzinga
Why Is Foot Locker (FL) Stock Down 31% Today?
August 23, 2023
Foot Locker (FL) stock is taking a beating on Wednesday after the athletic wear retailer released its Q2 earnings report.
Via
InvestorPlace
Why Is AMC Entertainment (AMC) Stock Down 20% Today?
August 23, 2023
AMC Entertainment (AMC) stock is falling on Wednesday as the movie theater company prepares for a stock conversion on Friday.
Via
InvestorPlace
Why AMC Entertainment Shares Are Trading Lower By 21%; Here Are 20 Stocks Moving Premarket
August 23, 2023
Gainers BioNexus Gene Lab Corp. (NASDAQ: BGLC) shares gained 48.5% to $2.05 in pre-market trading after jumping 30% on Tuesday.
Via
Benzinga
Why Is Apellis Pharmaceuticals (APLS) Stock Up 23% Today?
August 23, 2023
Apellis Pharmaceuticals (APLS) stock is on the rise Wednesday after the biopharmaceutical company announced an update on injection kits.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
August 23, 2023
It's time for another dive into the biggest pre-market stock movers as we break down all of the biggest news on Wednesday!
Via
InvestorPlace
Urban Outfitters, Toll Brothers And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
August 23, 2023
U.S. stock futures traded higher this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 22, 2023
Via
Benzinga
Apellis Provides Updates on Injection Kits and Rare Safety Events with SYFOVRE® (pegcetacoplan injection)
August 22, 2023
From
Apellis Pharmaceuticals, Inc.
Via
GlobeNewswire
3 Sorry Pharma Stocks to Sell in August Before It’s Too Late
August 22, 2023
Factors in the marketplace caused these companies to underperform, making them some of the top pharma stocks to sell.
Via
InvestorPlace
APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Apellis Pharmaceuticals, Inc.
August 22, 2023
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against RTX, Eos, and Apellis and Encourages Investors to Contact the Firm
August 21, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Want to Get Rich? 3 Game-Changing Biotech Stocks to Buy Right Now
August 21, 2023
Biotech stocks may offer some of the most explosive opportunities on the market. Here are three with major catalysts nearing.
Via
InvestorPlace
NASDAQ: APLS Investor Alert: Lawsuit Alleges Misleading Statements by Apellis Pharmaceuticals, Inc.
August 21, 2023
San Diego, CA -- (SBWIRE) -- 08/21/2023 -- An investor, who purchased shares of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), filed a lawsuit over alleged violations of Federal Securities Laws by...
Via
SBWire
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, A TOP RANKED FIRM, Encourages Apellis Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLS
August 19, 2023
WHY: NEW YORK, NY - (NewMediaWire) - August 19, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) between...
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Apellis Pharmaceuticals, Inc. (APLS)
August 18, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
August 17, 2023
Via
Benzinga
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Apellis Pharmaceuticals, Inc. (APLS)
August 17, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against RTX, Eos, and Apellis and Encourages Investors to Contact the Firm
August 16, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Apellis Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – APLS
August 16, 2023
From
The Rosen Law Firm PA
Via
GlobeNewswire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Apellis Pharmaceuticals, Inc. (APLS) Investors
August 15, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
August 14, 2023
Via
Benzinga
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Apellis Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - APLS
August 14, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Apellis Pharmaceuticals, Inc. (APLS) Investors
August 14, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.